AHR Form 4 reports disposition transactions

Oh Stefan K.L. reported disposition transactions in a Form 4 filing for AHR.

Rhea-AI Filing Summary

Oh Stefan K.L. reported disposition transactions in a Form 4 filing for AHR. The filing lists transactions totaling 10,166 shares at a weighted average price of $48.77 per share. Following the reported transactions, holdings were 85,505 shares.

Insider Trade Summary

Exercise Price or Tax Liability: 10,166 shares

Exercise Price or Tax Liability 1 txn

Insider Oh Stefan K.L.

Role Chief Investment Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	10,166	$48.77	$496K

Holdings After Transaction: Common Stock — 85,505 shares (Direct)

Footnotes (1)

1. F1. Represents shares repurchased by the Issuer on February 9, 2026 to satisfy the Reporting Person's tax obligations associated with the vesting of shares of restricted common stock on February 9, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did American Healthcare REIT (AHR) report for Stefan K.L. Oh?

American Healthcare REIT (AHR) reported a tax-withholding share disposition by Chief Investment Officer Stefan K.L. Oh. On February 9, 2026, 10,166 common shares were repurchased by the company at $48.77 per share to satisfy his tax obligations from restricted stock vesting.

Was the American Healthcare REIT (AHR) insider transaction an open-market sale?

No, the American Healthcare REIT (AHR) transaction was not an open-market sale. The 10,166 shares were repurchased by the issuer on February 9, 2026 to cover Stefan K.L. Oh’s tax liabilities arising from vesting restricted common stock, a standard equity compensation-related event.

How many American Healthcare REIT (AHR) shares does Stefan K.L. Oh own after the reported transaction?

After the reported transaction, Stefan K.L. Oh beneficially owns 85,505 AHR shares. This figure reflects his direct ownership following the February 9, 2026 tax-withholding disposition of 10,166 shares repurchased by American Healthcare REIT to satisfy his tax obligations.

What was the price per share in the American Healthcare REIT (AHR) insider tax-withholding transaction?

The tax-withholding disposition used a price of $48.77 per AHR share. American Healthcare REIT repurchased 10,166 common shares from Chief Investment Officer Stefan K.L. Oh at this price on February 9, 2026 to cover taxes owed on vesting restricted stock.

What does transaction code "F" mean in the American Healthcare REIT (AHR) Form 4?

Transaction code "F" indicates a tax-withholding disposition of shares. For American Healthcare REIT (AHR), it reflects that 10,166 common shares were withheld and repurchased by the issuer to pay Stefan K.L. Oh’s tax liability from restricted stock vesting on February 9, 2026.

What role does Stefan K.L. Oh hold at American Healthcare REIT (AHR)?

Stefan K.L. Oh serves as Chief Investment Officer of American Healthcare REIT (AHR). His Form 4 filing reports a routine equity compensation-related transaction, where company shares were used to satisfy tax obligations tied to vesting restricted common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/11/2026 - 04:23 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Oh Stefan K.L.

(Last) (First) (Middle)

18191 VON KARMAN AVENUE

THIRD FLOOR

(Street)

IRVINE CA 92612

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Investment Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		F		10,166(1)	D	$48.77	85,505	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares repurchased by the Issuer on February 9, 2026 to satisfy the Reporting Person's tax obligations associated with the vesting of shares of restricted common stock on February 9, 2026.

	/s/ STEFAN K.L. OH	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.